The 30-day risk for death was slightly higher for COVID-19 than for influenza or RSV; the 180-day mortality also was higher for COVID-19.

New research showed some long COVID patients get symptom relief by taking an extended course of Paxlovid. Data are ...

A 36-year-old male from Pimplegurav, who worked as an Ola-Uber driver, was admitted to Yashwantrao Chavan Hospital on January ...

Maharashtra reported two more deaths on Friday due to the Guillain-Barre Syndrome, which is an immunological nerve disorder, ...

A 36-year-old male from Pimplegurav, who worked as an Ola-Uber driver, was admitted to Yashwantrao Chavan Hospital on January 21 due to suspected Guillain-Barre Syndrome (GBS).The patient's health ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report today in ...

The antibody targets a stable part of the bird flu virus, ensuring that the immune protection can resist new variants and offer long-term protection against the globally spreading airborne infection.

A 41-year-old man was evaluated for swelling in the ankles and syncope. CT of the chest showed bilateral mediastinal and ...

The risk for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is increased following COVID-19, according to a study.

Distinct protein profiles linked to inflammation and angiogenesis found in children with Long COVID, paving the way for ...

U.S. surges of COVID-19, influenza, respiratory syncytial virus (RSV) and norovirus have collectively been dubbed a ...